Clinical Study
C4671026: Study drugs for Children with COVID-19 in Children
Nirmatrelvir and Ritonavir are study drugs for children with COVID-19. These study drugs are only approved by the federal drug administration (FDA) for adults. Research is needed to learn the effectiveness of the study drugs and find the best dose for children with COVID-19.
For more information contact:
Abbey Loveridge
abbey.loveridge@hsc.utah.edu
801.213.3954
IRB#: IRB_00155069
| PI: Justin Alvey
| Department: GENERAL PEDIATRICS
| Approval Date: 2022-12-21 07:00:00
Study Categories: COVID-19 Studies
| Specialties: Infectious Diseases
Who can participate?
Gender: All
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- Ages 0 to 17 years old
- Child with COVID-19
- At least one health issue that increases the risk of COVID-19
- In person at the University of Utah
Exclusion Criteria:
- Hospitalized for COVID-19
- Mental health condition within the past year before participation
- Medical condition or infection that may require being in the hospital or surgery
Will I be paid for my time?
Yes